全文获取类型
收费全文 | 5599篇 |
免费 | 265篇 |
国内免费 | 58篇 |
专业分类
耳鼻咽喉 | 63篇 |
儿科学 | 75篇 |
妇产科学 | 141篇 |
基础医学 | 422篇 |
口腔科学 | 172篇 |
临床医学 | 376篇 |
内科学 | 1426篇 |
皮肤病学 | 184篇 |
神经病学 | 518篇 |
特种医学 | 228篇 |
外科学 | 914篇 |
综合类 | 35篇 |
预防医学 | 323篇 |
眼科学 | 168篇 |
药学 | 262篇 |
中国医学 | 6篇 |
肿瘤学 | 609篇 |
出版年
2024年 | 5篇 |
2023年 | 38篇 |
2022年 | 97篇 |
2021年 | 142篇 |
2020年 | 95篇 |
2019年 | 107篇 |
2018年 | 151篇 |
2017年 | 104篇 |
2016年 | 151篇 |
2015年 | 162篇 |
2014年 | 245篇 |
2013年 | 302篇 |
2012年 | 441篇 |
2011年 | 513篇 |
2010年 | 278篇 |
2009年 | 265篇 |
2008年 | 453篇 |
2007年 | 457篇 |
2006年 | 400篇 |
2005年 | 388篇 |
2004年 | 327篇 |
2003年 | 283篇 |
2002年 | 230篇 |
2001年 | 35篇 |
2000年 | 23篇 |
1999年 | 39篇 |
1998年 | 42篇 |
1997年 | 27篇 |
1996年 | 23篇 |
1995年 | 11篇 |
1994年 | 13篇 |
1993年 | 3篇 |
1992年 | 10篇 |
1991年 | 3篇 |
1990年 | 2篇 |
1989年 | 2篇 |
1988年 | 7篇 |
1987年 | 4篇 |
1985年 | 2篇 |
1984年 | 4篇 |
1982年 | 4篇 |
1981年 | 4篇 |
1980年 | 8篇 |
1979年 | 4篇 |
1978年 | 3篇 |
1977年 | 2篇 |
1976年 | 2篇 |
1975年 | 2篇 |
1974年 | 3篇 |
1963年 | 1篇 |
排序方式: 共有5922条查询结果,搜索用时 0 毫秒
991.
Neuroanatomical abnormalities in schizophrenia: a multimodal voxelwise meta-analysis and meta-regression analysis 总被引:1,自引:0,他引:1
Bora E Fornito A Radua J Walterfang M Seal M Wood SJ Yücel M Velakoulis D Pantelis C 《Schizophrenia Research》2011,127(1-3):46-57
Despite an increasing number of published voxel based morphometry studies of schizophrenia, there has been no adequate attempt to examine gray (GM) and white matter (WM) abnormalities and the heterogeneity of published findings. In the current article, we used a coordinate based meta-analysis technique to simultaneously examine GM and WM abnormalities in schizophrenia and to assess the effects of gender, chronicity, negative symptoms and other clinical variables. 79 studies meeting our inclusion criteria were included in the meta-analysis. Schizophrenia was associated with GM reductions in the bilateral insula/inferior frontal cortex, superior temporal gyrus, anterior cingulate gyrus/medial frontal cortex, thalamus and left amygdala. In WM analyses of volumetric and diffusion-weighted images, schizophrenia was associated with decreased FA and/or WM in interhemispheric fibers, anterior thalamic radiation, inferior longitudinal fasciculi, inferior frontal occipital fasciculi, cingulum and fornix. Male gender, chronic illness and negative symptoms were associated with more severe GM abnormalities and illness chronicity was associated with more severe WM deficits. The meta-analyses revealed overlapping GM and WM structural findings in schizophrenia, characterized by bilateral anterior cortical, limbic and subcortical GM abnormalities, and WM changes in regions including tracts that connect these structures within and between hemispheres. However, the available findings are biased towards characteristics of schizophrenia samples with poor prognosis. 相似文献
992.
Chinopoulos C 《Journal of neuroscience research》2011,89(12):1897-1904
It was recently shown that, in progressively depolarizing mitochondria, the F(0) -F(1) ATP synthase and the adenine nucleotide translocase (ANT) may change directionality independently from each other (Chinopoulos et al. [2010] FASEB J. 24:2405). When the membrane potentials at which these two molecular entities reverse directionality, termed reversal potential (Erev), are plotted as a function of matrix ATP/ADP ratio, an area of the plot is bracketed by the Erev_ATPase and the Erev_ANT, which we call "B space". Both reversal potentials are dynamic, in that they depend on the fluctuating values of the participating reactants; however, Erev_ATPase is almost always more negative than Erev_ANT. Here we review the conditions that define the boundaries of the "B space". Emphasis is placed on the role of matrix substrate-level phosphorylation, because during metabolic compromise this mechanism could maintain mitochondrial membrane potential and prevent the influx of cytosolic ATP destined for hydrolysis by the reversed F(0) -F(1) ATP synthase. 相似文献
993.
994.
995.
Nikolaos S. Salemis Dionisios Pinialidis Evangelos Tsiambas Christos Gakis Georgios Nakos Dimitrios Sambaziotis Charalambos Christofyllakis 《Journal of gastrointestinal cancer》2011,42(3):131-136
Background—Purpose
The risk of secondary malignancy development in patients with hairy cell leukemia has been evaluated in several studies with varying results. The aim of this study is to describe a case of synchronous occurrence of neuroendocrine colon carcinoma and hairy cell leukemia.Methods
A 69-year-old man presented with rectal bleeding. Colonoscopy revealed a rectal tumor, whereas biopsy specimens revealed a poorly differentiated carcinoma. During the preoperative evaluation, pancytopenia was detected.Results
At laparotomy, a mass was detected 16 cm from the anal verge and an anterior resection of the rectum was performed. Detailed histological and immunohistochemical analyses revealed a poorly differentiated neuroendocrine carcinoma of the rectum. Postoperative evaluation of pancytopenia revealed hairy cell leukemia. The patient was initially treated with chemotherapy for hairy cell leukemia followed by chemotherapy for neuroendocrine colon carcinoma. Survival was 44 months.Conclusions
To our knowledge, synchronous occurrence of neuroendocrine colon carcinoma and hairy cell leukemia has not been previously reported in the literature. Given the rare incidence of both entities in the general population, it is highly unlikely that they occurred together by chance. Further research is needed to determine what would be the optimal management options of patients with simultaneous hairy cell leukemia and a neuroendocrine colon cancer. 相似文献996.
Anestis Charalampopoulos Alexander Charalabopoulos Anna Batistatou Christos Golias Antonia Anogeianaki Dimitrios Peschos Iosif Iliadis Anastasios Macheras Konstantinos Charalabopoulos 《Clinical and experimental medicine》2010,10(1):69-72
Experimental, epidemiologic, and clinical trial data indicate the antineoplastic effects of calcium and vitamin D in large-bowel
neoplasia. The aim of this study was to determine serum levels of vitamin D metabolites and parathormone (PTH) in patients
with colorectal cancer (CRC) and to extract conclusions comparing their different levels in serum with healthy individuals.
Group 1 (cancer patients) was consisted of 140 patients with CRC with clinical stages Duke’s A: 12, B: 52, C: 62, and D: 14.
Serum levels of 25(OH)D3, 1,25(OH)2D3, and PTH were determined in all patients. The findings are: (a) No significant difference was found in the serum levels of
25(OH)D3 in each Duke’s clinical stage in cancer patients, (b) serum 1,25(OH)2D3 levels decreased with advanced cancer stages, and (c) serum levels of PTH showed a corresponding increase. Low serum levels
of 1,25(OH)2D3 on one hand and increased levels of PTH in patients with CRC on the other might be strongly related to the carcinogenetic
process. 相似文献
997.
998.
Yi-Shin Kuo D Timmins P Blank SV Fields AL Goldberg GL Murgo A Christos P Wadler S Runowicz CD 《Gynecologic oncology》2006,100(1):160-165
OBJECTIVE: To define the efficacy of thalidomide on the overall survival of patients with metastatic recurrent gynecologic sarcomas. PATIENTS AND METHODS: All patients with sarcoma or carcinosarcoma of gynecologic origin and documented recurrence or persistence of disease after appropriate surgery, radiation therapy and/or chemotherapy were recruited to the study. All patients were ambulatory and had measurable disease that could be documented on CT scan. Patients were started on 200 mg/day of thalidomide orally every night and escalated by 100-200 mg every 7 to 14 days. The length of the treatment was separated into 2 cycles with the first 84 days defined as the first cycle and the next 56 days as the second cycle. Common Toxicity Criteria were used to record toxicities. Because thalidomide was postulated to induce cytostasis, the end-points were progression-free and overall survival in this mixed group of patients. RESULTS: Seventeen patients were enrolled. The drug was not well tolerated because of constipation, fatigue, worsening performance status, drowsiness and sleepiness. The total dosage of medication given to each patient ranged from 3200 mg to 40,500 mg. The maximum dosage reached in each patient ranged from 300 mg to 750 mg, with the total time of treatment ranging from 13 to 99 days. All patients had progression of disease with a median progression-free survival time of 1.84 months (CI 1.54-2.79 months) and a median overall survival of 6.64 months. DISCUSSION: Thalidomide has no activity in patients with advanced or recurrent gynecologic sarcomas and was not well-tolerated. The overall survival was <7 months. The progression-free survival was <3 months, and, since the therapy was not tolerated well, we unanimously decided to close the study at this point. Despite the poor result, we still believe in the strategy of anti-angiogenesis and will continue to pursue other potential treatment options using the same concept. 相似文献
999.
Role of the alpha-helical linker of the C-terminal translocator in the biogenesis of the serine protease subfamily of autotransporters 下载免费PDF全文
Autotransporters are secreted virulence factors that comprise three domains: an N-terminal signal peptide, an internal passenger domain, and a C-terminal beta-domain. The mechanism of passenger translocation across the outer membrane remains undefined, with four models having been proposed: the "hairpin," the "threading," the "multimeric," and the "Omp85 (YaeT)" models. In an attempt to understand autotransporter biogenesis, we screened the sequences of the serine protease subfamily of autotransporters (SPATEs) for conserved features indicative of a common secretion mechanism. Our analyses revealed a strictly conserved 14-amino-acid motif within the predicted alpha-helical linker region, upstream of the beta-domain of SPATEs. We investigated the function of this motif through a mutagenesis approach using Tsh as a model. Our studies demonstrate that mutations throughout the conserved motif do not block insertion of the beta-domain into the outer membrane. However, nonconservative mutations of four hydrophobic (V1099, L1102, G1107, and L1109) and three polar (N1100, K1104, and R1105) residues of the motif severely decrease or even abolish Tsh biogenesis. Further studies showed that these mutations interfere with passenger transport across the outer membrane. Bioinformatical analyses suggest that the critical polar and hydrophobic amino acids localize on opposite sides of the helix that runs through the beta-barrel pore. Our data indicate that the conserved motif is important for passenger secretion across the outer membrane and that mutations in certain residues severely affect the secretion process. We discuss how these results fit with the four proposed models for autotransporter secretion and potential applications in antimicrobial and vaccine development. 相似文献